DXC Technology and VMware Expand Global Partnership with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
91
DXC Technology and VMware Expand Global Partnership with New Managed Hybrid Cloud Services Enabled by VMware Technologies

LAS VEGAS, NV --(Marketwired - August 28, 2017) - DXC Technology ( NYSE : DXC ), the world's leading independent, end-to-end IT services company, and VMware ( NYSE : VMW ), a global leader in cloud infrastructure and business mobility, today announced an expansion of their long-standing partnership, with the unveiling of new DXC Managed Cloud Services enabled by VMware's next generation hybrid cloud services platforms.

The announcement was made at VMworld® 2017 U.S .

DXC will be one of the first VMware partners to provide VMware Cloud on AWS offerings with associated managed services. This new initiative enables DXC clients to accelerate their journey to the hybrid cloud while benefiting from an operationally consistent, resilient, secure and cost-effective hybrid cloud environment based on VMware Cloud on AWS.

  • With the initial availability of VMware Cloud on AWS, DXC clients can benefit from the full VMware software-defined data center (SDDC) experience, while taking advantage of the global footprint, scale, and flexible consumption model of the AWS Cloud.
  • Using familiar VMware enabled IT tools, methods, security policies and services, clients now will be able to accelerate their use of the leading public cloud service while maintaining the VMware-based architectural standards, security and services needed across their enterprise estates.

Additionally, clients will be able to obtain seamless workload portability between their VMware-based data centers, DXC data centers and VMware Cloud on AWS. Organizations will be able to select from a comprehensive portfolio of next-generation IT services, including application-as-a-service, application migration services, and application migration factories leveraging DXC IP in healthcare, public sector, manufacturing, financial services and other industries.

"Increasingly, clients want to accelerate the use of the public cloud for both core and emerging applications, yet there have been real barriers that impede adoption and progress," said Stephen Hilton , executive vice president, Global Delivery, DXC Technology. "For example, the full infrastructure ecosystem and application redesign forces a binary 'in or out' decision involving factors such as security, identify management, architectural standards and vendor management.

"By combining VMware's hybrid cloud offerings with DXC cloud services and industry expertise," Hilton continued, "we provide our clients the choice of both on-premises and cloud solutions on existing virtualized applications. This allows the business to make decisions based on cost, flexibility and availability that transcend the constraints of legacy datacenter and app hosting decisions. DXC's Hybrid Cloud Service is a true accelerator for enterprises wanting to modernize and optimize existing infrastructures in a flexible consumption model, while embracing the open services of the public cloud."

Additional DXC services enabled by VMware technologies and platforms will include:

  • Private Cloud services from DXC based on VMware vSphere, NSX®, VMware vSAN™, and VMware vRealize® Operations™ leveraging VMware Validated Designs and VMware Cloud Foundation™;
  • Public Cloud services based on VMware Cloud on AWS, including seamless workload portability between VMware-enabled private clouds and VMware Cloud on AWS;
  • Hybrid cloud automation, provisioning and workload management services utilizing VMware's next-generation hybridity and migration services platform and VMware vRealize Automation™ for VMware Cloud on AWS;
  • Cloud management services; and
  • Industry-specific cloud services.

"Together, VMware and DXC have a long-standing history of building, selling and delivering next-generation technology services to enable the digital transformation journey of our mutual clients, and we look forward to accelerating growth via this expanded partnership with DXC," said Pat Gelsinger , CEO, VMware. "DXC's Digital Transformation Services enabled by VMware's hybrid cloud services platforms will provide a consistent set of day-zero through day-two operations that delivers governance, security, visibility and control independent of how customers' applications are built and where they run."

DXC and VMware

DXC Technology and VMware, which is part of the DXC Partner Network , have built considerable competence and customer momentum around their VMware-enabled offerings, including DXC BizCloud and DXC MyWorkStyle for next generation digital workplace services.

DXC has several thousand mutual VMware clients in its portfolio and more than 1,000 trained and accredited VMware professionals. This expertise will equip DXC as a leader in VMware Cloud on AWS as the two companies deliver new sources of thought leadership and services innovation to their mutual clients.

About DXC Technology

DXC Technology is the world's leading independent, end-to-end IT services company, helping clients harness the power of innovation to thrive on change. Created by the merger of CSC and the Enterprise Services business of Hewlett-Packard Enterprise, DXC Technology serves nearly 6,000 private and public sector clients across 70 countries. The company's technology independence, global talent, and extensive partner alliances combine to deliver powerful next-generation IT services and solutions. DXC Technology is recognized among the best corporate citizens globally. For more information, visit http://www.dxc.technology/ .

About VMware

VMware, a global leader in cloud infrastructure and business mobility, helps customers realize possibilities by accelerating their digital transformation journeys. With VMware solutions, organizations are improving business agility by modernizing data centers and integrating public clouds, driving innovation with modern apps, creating exceptional experiences by empowering the digital workspace, and safeguarding customer trust by transforming security. With 2016 revenue of $7.09 billion, VMware is headquartered in Palo Alto, CA and has over 500,000 customers and 75,000 partners worldwide.

VMware, VMworld, VMware Cloud, vSphere, NSX, vSAN, vRealize, vRealize Operations, Cloud Foundation, and vRealize Automation are registered trademarks or trademarks of VMware, Inc. or its subsidiaries in the United States and other jurisdictions. Other trademarks or names mentioned in this press release belong to their respective owner.

Contact: Richard Adamonis Corporate Media Relations +1.862.228.3481 radamonis@dxc.com Donna Jenks Corporate Media Relations +1.630.306.9989 donna.jenks@dxc.com Jonathan Ford Investor Relations +1.703.245.9700 Investor.Relations@dxc.com Ken Lotich VMware Global Communications +1.916.740.4335 klotich@vmware.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading